Robert Lanza, Chief Scientific Officer at ADVANCED CELL TECHNOLOGY, INC. (ACTC), sold 1,500,000 shares at $0.08 ($120K) on 2014-07-03, disclosed to the SEC on 2014-07-07.
Scheduled sale ($120k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.08 | 755,000 | $60K | 50.3% |
| 2 | $0.08 | 745,000 | $60K | 49.7% |
| Total | $0.08 avg | 1,500,000 | $120K | 100% |
| Filing → |
| ACTC | SELL | 2012-08-01 | $160K | — | Filing → |
| ACTC | SELL | 2012-01-25 | $1.4M | — | Filing → |
| ACTC | SELL | 2011-09-30 | $109K | — | Filing → |